Table 3.
Characteristic | Group | Sequenced N = 563 n (%) |
Not Sequenced N = 342 n (%) |
Total N = 905 n (%) |
---|---|---|---|---|
Sex | Male | 456 (81.0) | 284 (83.0) | 740 (81.8) |
Female | 107 (19.0) | 58 (17.0) | 165 (18.2) | |
Age | 16–24 | 211 (37.5) | 98 (28.7) | 309 (34.1) |
25–34 | 150 (26.6) | 86 (25.1) | 236 (26.1) | |
35–44 | 91 (16.2) | 72 (21.1) | 163 (18.0) | |
45–54 | 70 (12.4) | 50 (14.6) | 120 (13.3) | |
55–64 | 34 (6.0) | 32 (9.4) | 66 (7.3) | |
65+ | 7 (1.2) | 4 (1.2) | 11 (1.2) | |
Race/ethnicity | American Indian | 2 (0.4) | 6 (1.8) | 8 (0.9) |
Asian | 13 (2.3) | 7 (2.0) | 20 (2.2) | |
Black | 217 (38.5) | 138 (40.4) | 355 (39.2) | |
Hispanic/Latino | 106 (18.8) | 57 (16.7) | 163 (18.0) | |
More than 1 race | 4 (0.7) | 9 (2.6) | 13 (1.4) | |
White | 203 (36.1) | 116 (33.9) | 319 (35.2) | |
Other | 4 (0.7) | 4 (1.2) | 8 (0.9) | |
Not available | 14 (2.5) | 5 (1.5) | 19 (2.1) | |
HHS census regiona | Midwest | 55 (9.8) | 45 (13.2) | 100 (11.0) |
Northeast | 44 (7.8) | 35 (10.2) | 79 (8.7) | |
South | 400 (71.1) | 205 (59.9) | 605 (66.9) | |
West | 63 (11.2) | 56 (16.4) | 119 (13.1) | |
Not available | 1 (0.2) | 1 (0.3) | 2 (0.2) | |
Year | 2015b | 32 (5.7) | 25 (7.3) | 57 (6.3) |
2016 | 114 (20.2) | 63 (18.4) | 177 (19.6) | |
2017 | 134 (23.8) | 58 (17.0) | 192 (21.2) | |
2018 | 124 (22.0) | 51 (14.9) | 175 (19.3) | |
2019 | 108 (19.2) | 73 (21.3) | 181 (20.0) | |
2020 | 51 (9.1) | 72 (21.5) | 123 (13.5) | |
Donation history | First-time | 394 (70.0) | 228 (66.7) | 612 (67.6) |
Repeat | 169 (30.0) | 114 (33.3) | 293 (32.4) |
Not sequenced includes those samples in which amplification was unsuccessful and infections where plasma was not available for sequencing.
aCensus region.
b1 September 2015–31 December 2015.